{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:52:51Z","timestamp":1790401971624,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["2016 850\/01"],"award-info":[{"award-number":["2016 850\/01"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.autrev.2016.09.022","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T21:36:07Z","timestamp":1474666567000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"16","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Roberta","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.09.022_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.autrev.2016.09.022_bb0010","first-page":"1130","article-title":"The Guillain\u2013Barr\u00e9 symptom complex","volume":"17","author":"Ropper","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.09.022_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00431-006-0140-1","article-title":"Infections and vaccinations preceding childhood Guillain\u2013Barr\u00e9 symptom complex: a prospective study","volume":"165","author":"Schessl","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2016.09.022_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00019052-199908000-00004","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"12","author":"Ho","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/ana.410270704","article-title":"The epidemiology of Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Alter","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.09.022_bb0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain\u2013Barr\u00e9 syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.09.022_bb0040","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain\u2013Barr\u00e9 syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0045","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/qjmed\/77.3.1297","article-title":"Age-specific incidence of Guillain\u2013Barr\u00e9 syndrome in Oxfordshire","volume":"77","author":"Winner","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2016.09.022_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.1988.tb03632.x","article-title":"Guillain\u2013Barr\u00e9 syndrome; diagnostic criteria, epidemiology, clinical course and prognosis","volume":"78","author":"Halls","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2016.09.022_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1542\/pir.33-4-164","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"33","author":"Beth","year":"2012","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.autrev.2016.09.022_bb0060","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.09.022_bb0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","article-title":"Mild forms of Guillain\u2013Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands","volume":"54","author":"van Koningsveld","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.09.022_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0404.2004.00272.x","article-title":"Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy","volume":"110","author":"Bogliun","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2016.09.022_bb0075","first-page":"1","article-title":"Guillain\u2013Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment","author":"Jasti","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2015.11.005","article-title":"Guillain Barr\u00e9 syndrome (GBS): new insights in the molecular mimicry between C. jejuni and human peripheral nerve (HPN) proteins","volume":"289","author":"Loshaj-Shala","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cir074","article-title":"Guillain\u2013Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study","volume":"52","author":"Orlikowski","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2016.09.022_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B978-0-444-53488-0.00013-4","article-title":"Epstein\u2013Barr virus infections of the nervous system","volume":"123","author":"Tselis","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3201\/eid2102.131879","article-title":"Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain\u2013Barr\u00e9 syndrome","volume":"21","author":"Hawken","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.autrev.2016.09.022_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-015-0047-0","article-title":"Risk of Guillain\u2013Barr\u00e9 syndrome after exposure to pandemic influenza a(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study","volume":"31","author":"Ghaderi","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24755","article-title":"Mycoplasma pneumoniae triggering the Guillain\u2013Barr\u00e9 syndrome: a case\u2013control study","author":"Meyer Sauteur","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0110","first-page":"21","article-title":"Cluster of atypical adult Guillain\u2013Barr\u00e9 syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016","volume":"2016","author":"Williams","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.autrev.2016.09.022_bb0115","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain\u2013Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case\u2013control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.09.022_bb0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJMp1602708","article-title":"Zika virus as a cause of neurologic disorders","volume":"374","author":"Broutet","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.09.022_bb0125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","article-title":"Zika virus and autoimmunity: from microcephaly to Guillain\u2013Barr\u00e9 syndrome, and beyond","volume":"15","author":"Lucchese","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.022_bb0130","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.autrev.2016.04.003","article-title":"Reply concerning the article \"Zika virus and autoimmunity: from microcephaly to Guillain\u2013Barr\u00e9 syndrome, and beyond\"","volume":"15","author":"Lucchese","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.022_bb0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/jnnp.2009.185504","article-title":"Rabies viral encephalitis: clinical determinants in diagnosis with special reference to paralytic form","volume":"81","author":"Gadre","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2016.09.022_bb0140","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain\u2013Barr\u00e9 syndrome and influenza vaccines: a meta-analysis","volume":"33","author":"Mart\u00edn Arias","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2016.09.022_bb0145","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2016.07.019","article-title":"Adverse events following pandemic influenza a (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009\u20132010 season in the active component U.S. military and civilians aged 17\u201344years reported to the Vaccine Adverse Event Reporting System","volume":"34","author":"Bardenheier","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2016.09.022_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain\u2013Barr\u00e9 syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2016.09.022_bb0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ilar\/ilt054","article-title":"Animal models of autoimmune neuropathy","volume":"54","author":"Soliven","year":"2014","journal-title":"ILAR J"},{"key":"10.1016\/j.autrev.2016.09.022_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.intimp.2016.08.019","article-title":"Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies","volume":"40","author":"Sudo","year":"2016","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.autrev.2016.09.022_bb0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain\u2013Barr\u00e9 syndrome. Epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2016.09.022_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/CND.0000000000000091","article-title":"Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain\u2013Barr\u00e9 syndrome","volume":"17","author":"DiCapua","year":"2015","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.autrev.2016.09.022_bb0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/14760584.2016.1123098","article-title":"T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity","volume":"15","author":"Moise","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.autrev.2016.09.022_bb0180","first-page":"1462","article-title":"Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques desrefl exes tendineux","volume":"28","author":"Guillain","year":"1916","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"10.1016\/j.autrev.2016.09.022_bb0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.autrev.2014.01.033","article-title":"Guillain Barr\u00e9 syndrome and other immune mediated neuropathies: diagnosis and classification","volume":"13","author":"Eldar","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.09.022_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain\u2013Barr\u00e9 syndrome: a randomized trial","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2016.09.022_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome","volume":"9","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2016.09.022_bb0200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"62","author":"Anand","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.autrev.2016.09.022_bb0205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"352","author":"Hahn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2016.09.022_bb0210","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/WNL.0000000000000481","article-title":"Paraparetic Guillain\u2013Barr\u00e9 syndrome","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.09.022_bb0215","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00415-011-6330-4","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with normal or exaggerated tendon reflexes","volume":"259","author":"Yuki","year":"2012","journal-title":"J Neurol"},{"issue":"Pt 1","key":"10.1016\/j.autrev.2016.09.022_bb0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain\u2013Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.09.022_bb0225","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of the motor\u2013sensory axonal Guillain\u2013Barr\u00e9 syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0240","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e31820e7b62","article-title":"Recognizing Guillain\u2013Barr\u00e9 syndrome in preschool children","volume":"76","author":"Roodbol","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.09.022_bb0250","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.291.6494.535","article-title":"Coma and brain stem areflexia in brain stem encephalitis (Fisher's syndrome)","volume":"291","author":"Al-Din","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2016.09.022_bb0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jns5.12068","article-title":"Long-term outcome of Guillain\u2013Barr\u00e9 syndrome in children","volume":"19","author":"Roodbol","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2016.09.022_bb0260","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.09.022_bb0265","article-title":"Intravenous immunoglobulin in the treatment of neurologic disorders","author":"\u017divkovi\u0107","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2016.09.022_bb0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jns5.12051","article-title":"Health-related quality of life in Guillain\u2013Barr\u00e9 syndrome patients: a systematic review","volume":"19","author":"Darweesh","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2016.09.022_bb0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/MOP.0b013e328365ad3f","article-title":"Pediatric Guillain\u2013Barr\u00e9 syndrome","volume":"25","author":"Ryan","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.autrev.2016.09.022_bb0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jns.12104","article-title":"Cytoalbuminologic dissociation in Asian patients with Guillain\u2013Barr\u00e9 and Miller Fisher syndromes","volume":"20","author":"Wong","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2016.09.022_bb0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/adc.2004.065706","article-title":"Management of children with Guillain\u2013Barr\u00e9 syndrome","volume":"92","author":"Agrawal","year":"2007","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.autrev.2016.09.022_bb0290","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain\u2013Barr\u00e9 syndrome","volume":"67","author":"Walgaard","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain\u2013Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2016.09.022_bb0300","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00381-010-1197-8","article-title":"Magnetic resonance imaging of childhood Guillain\u2013Barr\u00e9 syndrome","volume":"26","author":"Yikilmaz","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.autrev.2016.09.022_bb0305","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3174\/ajnr.A2358","article-title":"Redefining the Guillain\u2013Barr\u00e9 spectrum in children: neuroimaging findings of cranial nerve involvement","volume":"32","author":"Zuccoli","year":"2011","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0310","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.it.2013.05.001","article-title":"Glycolipid antigens and autoantibodies in autoimmune neuropathies","volume":"34","author":"Willison","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009950.pub3","article-title":"Pharmacological treatment for pain in Guillain\u2013Barr\u00e9 syndrome","volume":"4","author":"Liu","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2016.09.022_bb0320","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain\u2013Barr\u00e9 syndrome: a long-term follow-up study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2016.09.022_bb0325","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1080\/21645515.2015.1061161","article-title":"The usefulness of immunotherapy in pediatric neurodegenerative disorders: a systematic review of literature data","volume":"11","author":"Vitaliti","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.autrev.2016.09.022_bb0330","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"62","author":"Pithadia","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.autrev.2016.09.022_bb0335","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000050798","article-title":"Successful treatment of Guillain\u2013Barr\u00e9 syndrome with combined administration of interferon-beta-1 and intravenous immunoglobulin","volume":"46","author":"Schaller","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2016.09.022_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/bmt.2008.81","article-title":"Rituximab-responsive Guillain\u2013Barr\u00e9 syndrome following allogeneic hematopoietic SCT","volume":"42","author":"Ostronoff","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216302178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216302178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:24:47Z","timestamp":1718810687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216302178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1568997216302178"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.022","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain\u2013Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}